Skip to main content
Toggle navigation
Search
Home
Back
Favorite
0
Like
Facebook
Print
Session XXII: Colorectal Cancer: Metastatic Disease
LBA-2: MOUNTAINEER: Open-label, phase 2 study of tucatinib in combination with trastuzumab for HER2-positive metastatic colorectal cancer (SGNTUC-017)
Saturday, July 2, 2022
12:35 – 12:47
Location: Auditorium A; Level 0
Abstract Presenter(s)
JS
Jonathan Strickler, MD
